Literature DB >> 7977091

Fate of side branches after intracoronary implantation of the Gianturco-Roubin flex-stent for acute or threatened closure after percutaneous transluminal coronary angioplasty.

W Mazur1, W C Grinstead, A H Hakim, S F Dabaghi, J M Abukhalil, N M Ali, J Joseph, B A French, A E Raizner.   

Abstract

Side branch occlusion may occur in the course of percutaneous transluminal coronary angioplasty (PTCA), particularly if complicated by site dissection. Concern that the additional placement of a stent may further jeopardize side branches is logical. Consequently, this study analyzed pre-PTCA, post-PTCA, poststent, and 6-month follow-up angiograms of 100 consecutive patients in whom 103 Gianturco-Roubin stents were implanted for acute or threatened closure after PTCA. Side branches were defined as major (> 50% of the stented vessel diameter) and minor (< 50%). Minor branches, often < 1 mm in diameter, were assessed only for patency. One hundred eight major branches, of which 33 were diseased (> 50% stenosis), and 129 minor branches were analyzed. Seven major branches (6%), all of which were diseased before PTCA, and 23 minor branches (18%) were lost after PTCA. Immediately after stent insertion, only 1 additional major and 1 minor branch were lost, whereas 2 of 7 major (29%) and 9 of 23 minor (39%) branches reappeared. At follow-up angiography, 7 major branches (6%) were more stenosed and 6 (6%) were improved compared with the angiogram before PTCA. Only 2 major (2%) and 5 minor (4%) branches remained occluded. Additionally, 2 major and 1 minor branch, which were patent after PTCA and stenting, were occluded at follow-up as a result of total occlusion of the stented segment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7977091     DOI: 10.1016/0002-9149(94)90549-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis.

Authors:  Bong-Ki Lee; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Jung-Min Ahn; Hae Geun Song; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Jae-Hwan Lee; In-Whan Seong; Seong-Wook Park; Seung-Jung Park
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

2.  Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery.

Authors:  Cheng-Hung Lee; Yu-Huang Lin; Shang-Hung Chang; Chun-Der Tai; Shih-Jung Liu; Yen Chu; Chao-Jan Wang; Ming-Yi Hsu; Hung Chang; Gwo-Jyh Chang; Kuo-Chun Hung; Ming-Jer Hsieh; Fen-Chiung Lin; I-Chang Hsieh; Ming-Shien Wen; Yenlin Huang
Journal:  Int J Nanomedicine       Date:  2014-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.